A glutathione injection delivers glutathione, the body's most abundant natural antioxidant, directly into a vein.2,3 The IV glutathione products in the FDA's 2026 reports were made by compounding pharmacies, and compounded drugs are not FDA-approved.1,2 The injected form has limited trial evidence: a small Parkinson's disease pilot found no symptom change beyond placebo that reached statistical significance, and one placebo-controlled skin study missed statistical significance.5,6 If you are considering one, the useful questions are what goal it serves for you and where the glutathione comes from.
What Glutathione Is
Glutathione is a molecule your body makes on its own. Researchers describe it as the most abundant antioxidant made in the body and a regulator of oxidative stress and immune function.3 Oxidative stress is damage from reactive molecules, and it links to the chronic low-grade inflammation covered in inflammaging.
Because glutathione is so common in the body, supplements and injections promise to top it up. The open question for you is whether adding more from outside changes anything you can measure or feel. The answer depends on the route you use and the goal you have.
FDA Status of Compounded Glutathione Injections
The glutathione injections in the FDA's 2026 adverse event reports were prepared by compounding pharmacies.2 The FDA states that compounded drugs are not FDA-approved. The agency does not review their safety, effectiveness or quality before they are marketed.1
The FDA also notes that compounded drugs can serve a real medical need. A compounded drug that fails quality standards, for example through contamination, could cause serious injury or death.1 That makes the pharmacy and its ingredients part of your decision. If a clinic offers you a glutathione injection, you are entitled to ask who compounded it and what grade of ingredient they used.
The 2026 FDA Notice on Supplement-Grade Glutathione
In August 2026, the FDA reported at least 30 patients with adverse events after receiving IV glutathione, alone or combined with other ingredients.2 Several compounding pharmacies had made the products from glutathione obtained from one supplier. That glutathione was labeled dietary supplement grade, which the FDA says is not appropriate for making injectable drugs.2
Reported reactions included fever, chills, pain, dizziness, and signs of shock and sepsis-like symptoms. Some led to hospitalization.2 The FDA said these symptoms are consistent with exposure to excess endotoxin, a toxic component of bacteria.2 Supplement-grade ingredients may contain impurities and contaminants, including endotoxins, that can be harmful when injected.2
The FDA had communicated about this problem in 2019 and remains concerned about continued risks.2 Its advice is that health care professionals check with their compounders about the source of the glutathione they use.2 For you, that translates into one plain question before any injection: what is the source and grade of this glutathione?
Injected Glutathione in Clinical Trials
The clearest trial of injected glutathione tested it in Parkinson's disease. In a randomized, double-blind pilot, 21 people whose motor symptoms were not controlled by their medicines received IV glutathione or placebo.5
Symptom score changes did not differ between the groups to a degree that reached statistical significance.5 Glutathione was well tolerated, adverse events were similar to placebo, and no safety concerns were identified.5 The authors described a possible mild effect that would need a larger study to confirm.5
Injected glutathione was well tolerated in this supervised trial, and this small group showed no measurable benefit. If a clinic describes a glutathione drip as proven for energy, detox or recovery, ask which trial supports that use.
Skin Lightening Evidence
Skin lightening is a common reason people seek glutathione, and glutathione supplements are commonly used for that purpose in Asia.4 Glutathione reduces melanin production in the skin and acts as an antioxidant, which led to its use for this purpose.6
A 2025 systematic review found that oral glutathione reduced the melanin index compared with placebo in five randomized trials.6 Topical and oral forms gave moderate lightening, which the review described as unsustainable.6 For IV glutathione, the review found only one placebo-controlled study. In it, the review reported 37.5% (6 of 16) in the glutathione group versus 18.7% on placebo, a difference that did not reach statistical significance.6 The authors concluded that IV glutathione is contraindicated for skin lightening, given the lack of efficacy and its side effects.6
An earlier review of four studies judged the skin-whitening evidence inconclusive because of study quality and inconsistent findings.4 Practical takeaway: if your goal is your skin, the oral and topical evidence is stronger than the injected evidence, and a physician can help you choose based on your skin concern.
Oral Glutathione and Precursors
A 2019 review called oral glutathione's effect questionable because of limited absorption and bioavailability.4 A six-month randomized trial in 54 healthy non-smoking adults measured blood levels directly. Glutathione levels in blood rose at one, three and six months compared with baseline.3 Levels returned to baseline one month after stopping.3
Another approach supplies glycine and N-acetylcysteine instead of glutathione itself. In a small trial of older adults, the combination (GlyNAC) taken for 16 weeks corrected glutathione deficiency and oxidative stress, while placebo did not.7 Only 12 older adults received GlyNAC, so this result needs larger confirmation.7
These studies give you options that do not involve a needle. Your physician can weigh them against your goal and your labs, and then decide whether an injection adds anything.
How a Physician Decides Whether Glutathione Fits You
A physician starts by asking what you want glutathione to do. Skin, energy, recovery and weight each have a different evidence base and a different set of causes to check first.
If an injection is still on the table, the source matters as much as the molecule. The FDA's advice to check the glutathione's source applies to any glutathione injection you are offered.2 The FDA expects compounders to use ingredients made to specifications appropriate for injection, which is the standard to ask any pharmacy about.2
You and your physician should also agree on what improvement means before you start. A measurable goal, such as a skin assessment or a lab marker, gives you a fair way to decide whether to continue. For comparison with other infusions, NAD+ IV therapy and Lipo-C injections each have their own evidence base.
The Opt Take on Glutathione Injections
Glutathione is a molecule your body already makes, so the useful starting point is finding out what is driving the symptom you want to fix. At Opt Health, that starts with a blood panel of 55+ biomarkers spanning hormones, inflammation, cardiovascular risk and more. A physician reads your results with you 1:1.
If weight is your reason for looking at glutathione, an Opt Health physician's weight evaluation examines insulin, leptin, ghrelin, cortisol, sex hormones and thyroid, along with your metabolic rate, sleep, eating habits and stress. If energy is your reason, the evaluation examines cortisol, insulin, sex hormones, thyroid, sleep apnea, gut problems and nutritional deficiencies.
Your plan can include prescriptions, peptides and supplements shipped from our pharmacy to your home. Labs and a physician consultation repeat every 3 to 4 months, so your plan is adjusted on what your numbers did.
Get started: Begin with Opt Health, where a physician reads your labs, builds your plan, and adjusts it over the loop.
Frequently Asked Questions
Glutathione injections are commonly sought for skin lightening, along with antioxidant and wellness goals.6 The evidence for injected glutathione is limited: a small Parkinson's pilot found no symptom difference that reached statistical significance, and the single placebo-controlled IV skin study missed statistical significance.5,6 Your physician can tell you whether your goal has better-supported options.
Glutathione IV is glutathione delivered through a vein. The IV products in the FDA's 2026 reports were compounded.2 Compounded drugs are not FDA-approved, and the FDA does not review their safety, effectiveness or quality.1 In 2026, the FDA reported adverse events from IV glutathione made with supplement-grade ingredients, so ask about the source before any infusion.2
An IV injection places glutathione directly into the bloodstream, bypassing the gut. Glutathione acts as an antioxidant and regulator of oxidative stress and immune function.3 In skin, it reduces melanin production.6 Whether injected glutathione changes an outcome you care about has little trial support, so your physician can set a clear goal to test it against.5,6
Glutathione injections for skin are IV treatments marketed to lighten skin tone. A 2025 systematic review found one placebo-controlled IV study, which missed statistical significance, and the authors judged IV glutathione contraindicated for skin lightening.6 Oral and topical forms had better evidence, though the review described their effects as unsustainable.6 A physician can help you choose an approach for your skin concern.
In a supervised Parkinson's trial, IV glutathione had adverse events similar to placebo.5 The FDA's 2026 notice describes a separate risk from supplement-grade ingredients. The FDA reported fever, chills, pain, dizziness and shock-like symptoms, some requiring hospitalization, after IV glutathione made with supplement-grade ingredients.2 Tell your physician about any reaction you have had to an infusion.
Whether glutathione fits your goal depends on what your labs show. An Opt Health membership pairs 55+ biomarkers with a 1:1 physician review, then repeats labs and a physician consultation every 3 to 4 months.
References
- U.S. Food and Drug Administration. Understanding the risks of compounded drugs. Content current as of June 22, 2026. Accessed October 14, 2026. https://www.fda.gov/drugs/human-drug-compounding/understanding-risks-compounded-drugs
- U.S. Food and Drug Administration. FDA reminds compounders not to use dietary supplement grade glutathione for injectables. August 27, 2026. Accessed October 14, 2026. https://www.fda.gov/drugs/human-drug-compounding/fda-reminds-compounders-not-use-dietary-supplement-grade-glutathione-injectables
- Richie JP Jr et al. Randomized controlled trial of oral glutathione supplementation on body stores of glutathione. Eur J Nutr. 2015;54(2):251-263. https://pubmed.ncbi.nlm.nih.gov/24791752/
- Dilokthornsakul W et al. The clinical effect of glutathione on skin color and other related skin conditions: a systematic review. J Cosmet Dermatol. 2019;18(3):728-737. https://pubmed.ncbi.nlm.nih.gov/30895708/
- Hauser RA et al. Randomized, double-blind, pilot evaluation of intravenous glutathione in Parkinson's disease. Mov Disord. 2009;24(7):979-983. https://pubmed.ncbi.nlm.nih.gov/19230029/
- Sarkar R et al. Glutathione as a skin-lightening agent and in melasma: a systematic review. Int J Dermatol. 2025;64(6):992-1004. https://pubmed.ncbi.nlm.nih.gov/39444151/
- Kumar P et al. Supplementing glycine and N-acetylcysteine (GlyNAC) in older adults improves glutathione deficiency, oxidative stress, mitochondrial dysfunction, inflammation, physical function, and aging hallmarks: a randomized clinical trial. J Gerontol A Biol Sci Med Sci. 2023;78(1):75-89. https://pubmed.ncbi.nlm.nih.gov/35975308/
This content is for informational purposes and does not replace evaluation, diagnosis, or treatment by a qualified medical professional.
This article is part of our guide to peptides. See how peptide therapy is prescribed and monitored at Opt Health.
Start Today
Your health, your terms. Discover how personalized care can transform not just the way you feel, but how you live.